How is Hyperlipidemia Diagnosed?

A person with Hyperlipidemia or abnormally high cholesterol or triglyceride levels may be assessed by an internal medicine specialist, cardiologist or endocrinologist. A lipid profile is the main test and usually measures total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides.

Non-HDL cholesterol, apolipoprotein B and lipoprotein(a) may further refine cardiovascular risk in selected patients. Blood glucose, thyroid, liver and kidney tests may identify secondary causes or factors that affect treatment choices.

How is Hyperlipidemia Treated Based on Severity?

Hyperlipidemia is not formally divided into mild, moderate and severe stages based on symptoms. Treatment intensity is determined mainly by the degree of lipid elevation and the person's risk of cardiovascular disease or pancreatitis. As lipid levels and cardiovascular risk increase, treatment generally becomes more intensive.

The table below summarises a practical treatment approach for Hyperlipidemia according to lipid level and overall risk:

Clinical Situation Typical Treatment Approach
Mild lipid elevation with low cardiovascular risk Heart-healthy diet, regular physical activity, weight management and repeat lipid testing.
Moderate lipid elevation or additional risk factors Lifestyle measures plus consideration of statin therapy according to overall cardiovascular risk.
Severe high LDL cholesterol, including LDL-C ≥190 mg/dL Maximally tolerated statin therapy, assessment for secondary or inherited causes and additional LDL-lowering medicine when required.
Established cardiovascular disease or very high cardiovascular risk Intensive LDL lowering, usually with a statin and additional non-statin treatment when targets are not reached.
Severe hypertriglyceridaemia Treatment of secondary causes, dietary changes and triglyceride-lowering therapy when needed to reduce pancreatitis risk.

People with LDL-C of 190 mg/dL or higher generally require intensive treatment even when symptoms are absent. Additional medicines may include ezetimibe, bempedoic acid or a PCSK9-targeting therapy when LDL cholesterol remains above the treatment goal.

Types of Hyperlipidemia and Their Treatment

Treatment for Hyperlipidemia also varies according to the lipid pattern and whether the condition is inherited. This helps determine whether LDL-lowering, triglyceride-lowering or combined treatment should be prioritised.

Different lipid patterns may require different treatment priorities. The table below outlines the main treatment-relevant types of hyperlipidemia:

Type Treatment Approach
Isolated high LDL cholesterol Lifestyle changes and statin-based treatment; non-statin medicines may be added if LDL remains above the treatment goal.
Mixed hyperlipidemia Treatment of both LDL cholesterol and triglycerides through lifestyle measures, statins and selected additional medicines.
Hypertriglyceridaemia Lifestyle treatment, correction of secondary causes and triglyceride-lowering medicines in selected patients.
Familial hypercholesterolaemia Early and intensive LDL lowering, often using combination therapy with specialist follow-up.
Homozygous familial hypercholesterolaemia Specialist treatment with intensive combination therapy and selected advanced treatments such as evinacumab or lipoprotein apheresis.

Other Treatments for Hyperlipidemia

Other treatments for Hyperlipidemia are given below:

  1. PCSK9 Monoclonal Antibodies Alirocumab and evolocumab are injectable medicines that can substantially lower LDL cholesterol in selected high-risk patients.

  2. Inclisiran Inclisiran is an injectable RNA-based treatment that lowers LDL cholesterol by reducing PCSK9 production and is administered less frequently than many other injectable therapies.

  3. Lipoprotein Apheresis This specialised blood-filtering procedure may be used in selected patients with severe familial hypercholesterolaemia when intensive drug treatment does not achieve adequate LDL-C reduction.

  4. Evinacumab Evinacumab is an advanced treatment considered for eligible patients with homozygous familial hypercholesterolaemia who remain above their LDL-C target despite maximum lipid-lowering treatment.

  5. Treatment of Underlying Conditions Managing hypothyroidism, diabetes, kidney disease, obesity and other secondary causes can form an important part of the treatment plan.

Oral Medications for Hyperlipidemia

The choice of medicine for Hyperlipidemia depends on the lipid abnormality, cardiovascular risk, treatment response, other health conditions and tolerance.

Common oral medicines for Hyperlipidemia are given below:

  • Statins: Atorvastatin, rosuvastatin, simvastatin, pravastatin and pitavastatin.

  • Cholesterol Absorption Inhibitor: Ezetimibe.

  • ATP Citrate Lyase Inhibitor: Bempedoic acid.

  • Fibrates: Fenofibrate and gemfibrozil, mainly used for selected triglyceride disorders.

  • Bile Acid Sequestrants: Cholestyramine, colestipol and colesevelam in selected patients.

  • Prescription Omega-3 Preparations: May be used for specific patients with raised triglycerides.

  • Niacin: Has a limited role in modern lipid management and is not routinely used for most patients.

Statins reduce cholesterol production in the liver and remain the first-line lipid-lowering medicine for many patients. Ezetimibe reduces cholesterol absorption in the intestine and is a commonly used non-statin option.

Ayurvedic and Alternative Treatments for Hyperlipidemia

Certain supportive approaches for Hyperlipidemia are as follows:

  • Yoga: May support regular physical activity and weight management.

  • Meditation and Stress Management: May support adherence to healthy lifestyle practices.

  • Ayurvedic Consultation: Should be used only as a complementary approach under qualified medical guidance.

  • Herbal Supplements: Should not be considered a substitute for prescribed treatment because supplements may interact with medicines.

No alternative therapy should be used as a substitute for statins or other evidence-based lipid-lowering medicines.

Home Care for Managing Hyperlipidemia

Home care mainly involves long-term adherence to the treatment plan and regular monitoring. Some of these measures are listed below:

  • Take prescribed lipid-lowering medicines regularly.

  • Follow the recommended dietary plan.

  • Maintain regular physical activity.

  • Monitor body weight where relevant.

  • Attend scheduled lipid profile tests.

  • Manage diabetes, hypertension and thyroid disease as advised.

  • Avoid smoking and tobacco products.

  • Limit alcohol intake, particularly when triglycerides are elevated.

  • Do not stop statins or other medicines without medical advice.

  • Inform the treating doctor about supplements, herbal products and over-the-counter medicines.

How Long Does Treatment for Hyperlipidemia Take?

Hyperlipidemia treatment is usually long-term because lipid levels may rise again if effective treatment is stopped. Treatment duration varies according to the medicine used, the underlying lipid abnormality and cardiovascular risk.

The table below summarises the approximate duration of major treatment approaches for Hyperlipidemia:

Treatment Approximate Duration
Lifestyle changes Long-term or lifelong
Statin therapy Usually long-term or lifelong when clinically indicated
Ezetimibe Long-term when required
Bempedoic acid Long-term when required
PCSK9 monoclonal antibodies Long-term, with dosing according to the prescribed product
Inclisiran Long-term, with injections according to the prescribed schedule
Fibrates for high triglycerides Depends on triglyceride levels and the underlying cause
Lipoprotein apheresis Repeated at intervals determined by the specialist

Repeat lipid testing helps assess response and guide changes in medication dose or combination.

Hyperlipidemia Treatment Side Effects

Hyperlipidemia treatment side effects depend on the medicine or procedure used. Common or important side effects may include:

  • Muscle aches, mild digestive symptoms and changes in liver enzyme levels.

  • Digestive symptoms, fatigue or muscle symptoms in some patients.

  • Raised uric acid levels, gout in susceptible individuals and other medicine-specific adverse effects.

  • Changes in liver function and muscle-related adverse effects may occur in some situations.

  • Constipation, bloating and abdominal discomfort.

  • Injection-site reactions and other treatment-specific effects.

  • Temporary low blood pressure, fatigue or procedure-related complications.

Patients should report unexplained muscle pain, severe weakness, dark urine or other symptoms to their doctor promptly.

Lifestyle Changes for the Treatment of Hyperlipidemia

Lifestyle changes are a central part of Hyperlipidemia treatment. These changes are given below:

  • Follow a diet rich in vegetables, fruits, whole grains, pulses and other high-fibre foods.

  • Choose unsaturated fats in appropriate amounts.

  • Reduce saturated fat intake.

  • Avoid industrial trans fats.

  • Choose lean protein sources.

  • Increase dietary fibre, particularly soluble fibre.

  • Maintain a healthy body weight.

  • Exercise regularly according to medical fitness and ability.

  • Stop smoking and avoid tobacco exposure.

  • Limit alcohol intake.

  • Control diabetes and high blood pressure.

  • Follow treatment for hypothyroidism or other underlying conditions.

Lifestyle changes and medication therapy are complementary. Healthy habits remain important even when cholesterol-lowering medicines are prescribed.

Triggers That Can Worsen the Symptoms of Hyperlipidemia

Certain triggers that can worsen the symptoms of Hyperlipidemia are listed below:

  • Diets high in saturated fats and trans fats

  • Excess intake of highly processed foods

  • Physical inactivity

  • Excess body weight

  • Poorly controlled diabetes

  • Excess alcohol intake

  • Untreated hypothyroidism

  • Certain kidney or liver disorders

  • Some medicines that affect lipid metabolism

  • Stopping prescribed lipid-lowering treatment

  • Poor adherence to dietary and exercise recommendations

The treating doctor should evaluate potentially reversible secondary causes before intensifying long-term treatment.

Treatment Cost of Hyperlipidemia in India

The cost of Hyperlipidemia treatment in India varies widely according to the medicines required. Mild cases managed with lifestyle counselling, periodic consultation and routine lipid testing may involve relatively low ongoing costs. The cost of a standard lipid profile is approximately ₹400 - ₹1,000, although prices vary by laboratory and location.

Generic oral medicines may also be relatively affordable, whereas severe familial hypercholesterolaemia requiring PCSK9-targeting injections, inclisiran, apheresis or other specialist therapies can result in substantially higher expenses.

Does Health Insurance Cover Treatment of Hyperlipidemia in India?

Yes. Health insurance provides coverage for Hyperlipidemia, depending on the policy. Routine medical consultations, laboratory tests and long-term outpatient medicines can be covered only if the policy comes with the OPD cover. Hospital treatment for covered cardiovascular complications is covered up to the policy's sum insured.

If Hyperlipidemia is present before the policy is purchased, it may be treated as a pre-existing condition. In such cases, a waiting period of up to 36 months may apply. Policyholders should check their exact coverage, OPD benefits, exclusions, co-payments and waiting periods before raising a claim.

Frequently asked questions (FAQs)

  • Q1. How can Hyperlipidemia be treated permanently?

    Ans: Yes. Some cases of Hyperlipidemia caused by reversible factors may improve when the underlying cause is treated. However, many people need long-term lifestyle changes and ongoing medication to keep lipid levels under control.
  • Q2. Which treatment is most effective for Hyperlipidemia?

    Ans: The most effective Hyperlipidemia treatment depends on the type of lipid abnormality and cardiovascular risk. Statins are the foundation of LDL cholesterol-lowering treatment for many patients, while ezetimibe, bempedoic acid or PCSK9-targeting therapies may be added when further LDL-C reduction is required.
  • Q3. How long does the treatment of Hyperlipidemia take?

    Ans: The treatment for Hyperlipidemia is often very long-term. Certain lifestyle changes should be maintained permanently, while lipid-lowering medicines may be required for years when cardiovascular risk remains higher.
  • Q4. Can Hyperlipidemia be treated without medicines?

    Ans: Some people with mild lipid abnormalities and low cardiovascular risk may initially be managed with lifestyle changes. However, people with severe LDL cholesterol elevation, established cardiovascular disease or a high overall cardiovascular risk may require medication.
  • Q5. What happens if statins do not lower cholesterol enough?

    Ans: If statins do not lower cholesterol, the doctor may increase the treatment of Hyperlipidemia treatment or add a non-statin medicine such as ezetimibe, bempedoic acid or a PCSK9 monoclonal antibody, depending on the required LDL-C reduction and the patient's cardiovascular risk.
  • Q6. What treatment is available for statin intolerance?

    Ans: The doctor may assess the cause of symptoms, adjust the statin regimen or use an evidence-based non-statin treatment. Bempedoic acid is among the options recommended in current ESC/EAS guidance for patients unable to take statins to achieve their LDL-C goal.
  • Q7. Can Ayurvedic medicine replace cholesterol-lowering medication?

    Ans: No. Ayurvedic or herbal products should not replace evidence-based treatment of Hyperlipidemia when medication is clinically required. Patients should discuss complementary therapies with their treating doctor because some products can interact with prescribed medicines.
  • Q8. Should cholesterol medication be stopped when the lipid profile becomes normal?

    Ans: No. A normal lipid level may reflect the effectiveness of Hyperlipidemia treatment. Stopping medication without medical advice can allow cholesterol levels and cardiovascular risk to increase again.
  • References

    • https://my.clevelandclinic.org/health/diseases/21656-Hyperlipidemia

    • https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-Hyperlipidemia

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC8363437/

    • https://www.webmd.com/cholesterol-management/Hyperlipidemia-overview

    • https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/reduce-cholesterol/art-20045935

    • https://www.nhs.uk/conditions/high-cholesterol/medicines-for-high-cholesterol/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC9647649/

Other Disease Treatment Pages